Keith Paulsen’s career demonstrates how multidisciplinary collaboration is driving the future of translational cancer research. By bringing together experts in engineering, medicine, imaging science, physics, and computer science, he has helped bridge the gap between laboratory innovation and clinical application. His work at Dartmouth highlights how collaborative teams can develop advanced imaging technologies, improve surgical precision, and accelerate the translation of research into real-world patient care, offering a powerful model for advancing cancer detection, diagnosis, and treatment through interdisciplinary innovation.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.